Braak staging of NFT pathology in AD was traditionally performed with Gallyas silver stain [64]; however, the AT8 antibody against tau phosphorylated at Ser202/Thr205 was found to be just as effective at tracking the progression of tau pathology [65, 66]. This evidence concerns the gene MAPT and Alzheimer disease.